Skip to main content
ALCIDION GROUP LIMITED logo

ALCIDION GROUP LIMITED — Investor Relations & Filings

Ticker · ALC ISIN · AU000000ALC6 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 731 across all filing types
Latest filing 2017-07-09 Regulatory Filings
Country AU Australia
Listing ASX ALC

About ALCIDION GROUP LIMITED

https://www.alcidion.com

Alcidion Group Limited develops and delivers specialized software solutions designed to enhance patient safety and clinical productivity. The company’s core offering, Miya Precision, is an interoperable platform that consolidates data from disparate clinical systems to provide real-time insights, clinical decision support, and predictive analytics. Complementary products include Patientrack, which automates the monitoring of patient vitals and early warning scores, and Smartpage, a secure clinical communication and task management system. These integrated technologies facilitate digital transformation within hospital environments by streamlining workflows and reducing clinical risk. The company focuses on providing healthcare providers with actionable data to improve care delivery and operational efficiency.

Recent filings

Filing Released Lang Actions
Alcidion Announces Miya iScheduler 2 pages 66.5KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing the release of a new software product, Miya iScheduler, by Alcidion Group Limited. It contains no financial data, no regulatory filing references, no meeting or voting information, no management or board changes, no earnings or capital updates, and no legal or merger activity. The document is promotional and informational about a product launch, not a financial or regulatory report. Given the content and length (under 5,000 characters), it does not fit into any specific financial filing category and is best classified as a general Regulatory Filing (RNS) which serves as a fallback for miscellaneous announcements that do not fit other categories.
2017-07-09 English
Alcidion Investor Presentation May 2017 (ASX Spoltlight Seri 19 pages 3.2MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation prepared by Alcidion Group Limited, containing extensive information about the company's business model, market opportunity, management team, technology platform, recent contracts, financial highlights, and strategic outlook. It includes forward-looking statements, disclaimers, and detailed descriptions of the company's operations and growth prospects. The document is structured as a presentation with slides and images (omitted here), and it is clearly intended for investors or stakeholders to understand the company's position and potential. There are no actual financial statements, regulatory certifications, voting results, or legal proceedings detailed. The content aligns with an investor presentation focusing on financials, strategy, and market position rather than a formal report like an annual report or earnings release. The length (over 14,000 characters) and detailed content confirm it is not a brief announcement or a simple report publication notice. Therefore, the most appropriate classification is Investor Presentation (IP).
2017-05-28 English
Alcidion announce NZD1.60m contract with MidCentral DHB 3 pages 77.6KB
Regulatory Filings Classification · 95% confidence The document is a press release dated 25 May 2017 announcing a $NZD1.60 million contract between Alcidion Group Limited and MidCentral District Health Board for deployment of the Miya Platform. It describes the contract details, product features, and includes quotes from executives. There is no financial data, regulatory filing references, or report attachments. The content is an update on a contract and business development, not a financial report, audit, or regulatory filing. Therefore, it fits best as a general regulatory announcement about business activity, which falls under Regulatory Filings (RNS).
2017-05-24 English
Alcidion's Prof Malcolm Pradhan to present at eHealth QLD 16 pages 949.3KB
Investor Presentation Classification · 95% confidence The document is a press release dated 17 May 2017 from Alcidion Group Limited announcing that their Chief Medical Officer will present at the eHealth Queensland Conference. It includes a detailed presentation on AI-driven healthcare, deep learning applications in patient flow, and clinical decision support systems. The content is primarily a presentation or speech text rather than a formal financial or regulatory report. There are no financial statements, regulatory disclosures, or corporate governance details. The document is not an earnings release, annual report, or any regulatory filing. It is a detailed presentation aimed at investors and stakeholders about the company's technology and strategy in healthcare AI. Therefore, the most appropriate classification is Investor Presentation (IP). The document length (8202 characters) supports it being a full presentation rather than a brief announcement or summary.
2017-05-16 English
Alcidion announces Miya Smartpage 2 pages 67.5KB
Regulatory Filings Classification · 95% confidence The document is a press release dated 10 May 2017 from Alcidion Group Limited announcing the release of a new clinical communication product called Miya Smartpage. It describes the product features, partnership details, and benefits but does not contain any financial data, regulatory filings, or report references. There is no indication of financial results, management changes, voting results, or other regulatory disclosures. The content is promotional and product-focused, typical of a general corporate announcement or product launch. Given the absence of financial or regulatory report content, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2017-05-09 English
Alcidion to cease support for Remedy 2 pages 67.4KB
Regulatory Filings Classification · 95% confidence The document is a public announcement dated 24 April 2017 from Alcidion Group Limited regarding the cessation of support for a bespoke software solution previously developed for Remedy Healthcare. It discusses business strategy changes and product focus but contains no financial data, regulatory filings, voting results, or detailed reports. The document is relatively short (3,714 characters) and reads as a corporate press release or general regulatory announcement rather than a financial report or meeting material. There is no indication of it being an Annual Report, Earnings Release, or any other specific report type. It fits best as a Regulatory Filing (RNS) since it is a general corporate announcement that does not fit other categories.
2017-04-23 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.